This document discusses concepts related to the global health-tech industry. It provides an overview of key topics including the healthcare and life sciences industry in 2020, technologies and startups disrupting the status quo, a focus on the medical device industry globally and in India, and a concept note on syringe counterfeiting. The document also analyzes funding trends in 2020, highlights major disruptors like telemedicine, and provides snapshots on medical devices and new anti-counterfeiting technologies.
US Healthcare Reimbursement for MedTech & Digital HealthLevi Shapiro
Overview of the US healthcare reimbursement framework as it relates to MedTech and Digital Health companies by David Farber, Senior Partner, King & Spalding law firm. Includes Introduction FDA Approval vs. Reimbursement; Different Standards; Clinical Evidence Needed; The Three Keys to Reimbursement Coverage; Coding; Payment; What’s New for 2019 Reimbursement for MedTech; AI Solutions Tips for Successful Reimbursement
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
"Healthcare Services at Merck & Co". Presentation by Guy Eiferman, President of Healthcare Services and Solutions, Merck & Co., made at the mHealth Israel Investors Summit, June 29, 2015, in Jerusalem
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
US Healthcare Reimbursement for MedTech & Digital HealthLevi Shapiro
Overview of the US healthcare reimbursement framework as it relates to MedTech and Digital Health companies by David Farber, Senior Partner, King & Spalding law firm. Includes Introduction FDA Approval vs. Reimbursement; Different Standards; Clinical Evidence Needed; The Three Keys to Reimbursement Coverage; Coding; Payment; What’s New for 2019 Reimbursement for MedTech; AI Solutions Tips for Successful Reimbursement
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
"Healthcare Services at Merck & Co". Presentation by Guy Eiferman, President of Healthcare Services and Solutions, Merck & Co., made at the mHealth Israel Investors Summit, June 29, 2015, in Jerusalem
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
April 2013 StartUp Health Insights Funding ReportStartUp Health
See StartUp Health Insights (http://www.startuphealth.com/insights) for the most comprehensive digital health funding database. Apply to StartUp Health Academy here: http://www.startuphealth.com/about-us/application/
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
mHealth Israel_E-Health to Digital Health_Jeremy Brody_Kantar HealthLevi Shapiro
Jeremy Brody, Chief Strategy Officer, Kantar Health (WPP) uses data to advise healthcare industry players about strategies for addressing major challenges such as Patient education, Compliance and adherence, Patient – physicians connectivity and communications, Patient records, Patient communities and support, Pharma value add, Disease management / population health management. They do this through their extensive healthcare database of projectable, self-reported, “real-world” patient-level information, covering over 165 therapeutic conditions and 1 million respondents. Key Trends include an ever changing patient physician dynamic; High health related app adoption; Fitness as a driver for wearables adoption; Transition from web connected to mobile connected devices; Low awareness of web / mobile connected devices; Physicians very slow to recommend connected devices;
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementJGB1
Emerging healthcare markets are moving into new phases as access to care increases and clinical / payer administration becomes more established. Successful healthcare marketing ventures require a balanced clinical / cost value proposition based on each nation\'s specific healthcare delivery, government and payer model.
Aguai Solutions brings deep expertise in Digital Healthcare leveraging technologies across Web, Cloud, Mobile and AI.
Patients are increasingly searching for good care givers, care centers. Need for Healthcare Ecosystem to go Digital is even greater today than ever before
David Farber (http://bit.ly/2DFnvJ1), Head of the FDA and Reimbursement Practice at King & Spalding in Washington DC, leads a workshop for medtech and digital health companies seeking US reimbursement. He brings 30+ years of experience in US Healthcare reimbursement, lobbying and FDA regulatory issues. In addition to ongoing reimbursement challenges, 2020 will see a fundamental transformation in US medical reimbursement (http://bit.ly/2YWlYbt), particularly in digital health. That includes 394 Current Procedural Terminology (CPT) code changes, 248 new codes, 71 deletions and 75 revisions
This is a comprehensive report on medical devices interoperability in India
This report covers global developments in interoperability of medical devices
Specialty pharmaceutical-generic companies that expanded pipelines through M&A and revenue through price increases are now facing scrutiny on the sustainability of the traditional model and looking toward more investment in R&D.
Mercer Capital's Value Focus: Medical Device Manufacturers | Q4 2015 | Five T...Mercer Capital
Mercer Capital provides medical device manufacturers, related start-up enterprises, and private equity funds with valuation services, including purchase price allocation, 409a compliance, goodwill impairment testing, and other transaction and valuation advisory services.
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
To lead digital transformation, CIOs at pharmaceutical and medical device companies need to adopt new workstyles and mindsets, including C-level relationship-building and the ability to both catalyze innovation and find the talent to execute on it.
2014 Overview of significant trends in the life sciences (Biotechnology, Pharmaceutical, Device and Diagnostics) industry with Big Data in the Life Sciences featured articles.
April 2013 StartUp Health Insights Funding ReportStartUp Health
See StartUp Health Insights (http://www.startuphealth.com/insights) for the most comprehensive digital health funding database. Apply to StartUp Health Academy here: http://www.startuphealth.com/about-us/application/
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
mHealth Israel_E-Health to Digital Health_Jeremy Brody_Kantar HealthLevi Shapiro
Jeremy Brody, Chief Strategy Officer, Kantar Health (WPP) uses data to advise healthcare industry players about strategies for addressing major challenges such as Patient education, Compliance and adherence, Patient – physicians connectivity and communications, Patient records, Patient communities and support, Pharma value add, Disease management / population health management. They do this through their extensive healthcare database of projectable, self-reported, “real-world” patient-level information, covering over 165 therapeutic conditions and 1 million respondents. Key Trends include an ever changing patient physician dynamic; High health related app adoption; Fitness as a driver for wearables adoption; Transition from web connected to mobile connected devices; Low awareness of web / mobile connected devices; Physicians very slow to recommend connected devices;
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementJGB1
Emerging healthcare markets are moving into new phases as access to care increases and clinical / payer administration becomes more established. Successful healthcare marketing ventures require a balanced clinical / cost value proposition based on each nation\'s specific healthcare delivery, government and payer model.
Aguai Solutions brings deep expertise in Digital Healthcare leveraging technologies across Web, Cloud, Mobile and AI.
Patients are increasingly searching for good care givers, care centers. Need for Healthcare Ecosystem to go Digital is even greater today than ever before
David Farber (http://bit.ly/2DFnvJ1), Head of the FDA and Reimbursement Practice at King & Spalding in Washington DC, leads a workshop for medtech and digital health companies seeking US reimbursement. He brings 30+ years of experience in US Healthcare reimbursement, lobbying and FDA regulatory issues. In addition to ongoing reimbursement challenges, 2020 will see a fundamental transformation in US medical reimbursement (http://bit.ly/2YWlYbt), particularly in digital health. That includes 394 Current Procedural Terminology (CPT) code changes, 248 new codes, 71 deletions and 75 revisions
This is a comprehensive report on medical devices interoperability in India
This report covers global developments in interoperability of medical devices
Specialty pharmaceutical-generic companies that expanded pipelines through M&A and revenue through price increases are now facing scrutiny on the sustainability of the traditional model and looking toward more investment in R&D.
Mercer Capital's Value Focus: Medical Device Manufacturers | Q4 2015 | Five T...Mercer Capital
Mercer Capital provides medical device manufacturers, related start-up enterprises, and private equity funds with valuation services, including purchase price allocation, 409a compliance, goodwill impairment testing, and other transaction and valuation advisory services.
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
To lead digital transformation, CIOs at pharmaceutical and medical device companies need to adopt new workstyles and mindsets, including C-level relationship-building and the ability to both catalyze innovation and find the talent to execute on it.
2014 Overview of significant trends in the life sciences (Biotechnology, Pharmaceutical, Device and Diagnostics) industry with Big Data in the Life Sciences featured articles.
Webinar: Digital Health Strategy: Leveraging Emerging Technologies in HealthcareIntellectsoft
WEBINAR VIDEO - https://www.intellectsoft.net/l/31/webinar-digital-healthcare
JOIN OUR WEBINAR TO:
- Explore what changed for healthcare practices and operations during COVID-19 and predict what leaders can expect in terms of recovery;
- Discover today’s featured examples of our clients’ technology solutions that can help you provide better and more efficient services;
- Discuss how to evolve and adapt for the rest of 2020 and into 2021 using emerging technologies and more efficient solutions.
BEST FOR:
- Сhief Medical Officers
- Doctors Pharmaceuticals
- HR Department Outstaffing
- Telemedicine Workers
- Insurance Companies
- Pharmacies
- Laboratories
- Private Hospitals
- Academical Health Centres
- Private Healthcare Facilities
- Management Information Systems
https://www.intellectsoft.net/
FINN Partners Global State of Digital Health Q3 2022Levi Shapiro
Global State of Digital Health, Q3 2022, prepared by Finn Partners and Galen Growth.
While most analyses suggest digital health investment is declining, that’s a superficial assessment. Last year – when patients were separated from the health professional community – investors from all sectors jumped in with investments to learn and save their business models. That investment surge was from exuberance. Now, the monies being deployed are strategic. More important, 2022 numbers are far higher than the pre-pandemic equity invested in 2019.
While more than 60% of the total venture funding value comes from North America, on a regional level, the Middle East (primarily Israel by 92% and the United Arab Emirates) set record highs in venture funding in Q2 2022. Europe maintains momentum throughout 2022 and has not experienced the quarter-on-quarter decrease in venture funding seen in North America. Regions with increased investment correspond to established regulatory, public health and payer systems that prioritize digital health use. Israel – and Israeli-based entrepreneurs – need to keep their profiles high.
The Work Ahead in Life Sciences: Cures at the Speed of DigitalCognizant
Life sciences businesses have accelerated their digital-first journey to operate in a world where time-to-everything matters more than any other strategic imperative, according to our study.
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in medical tech and asks the experts what it all means.
Key Points:
Multi-million dollar investments don’t always mean success. Success looks different to each stakeholder involved in digital health.
The winners in digital health will be those who provide real solutions to problems at a reduced cost.
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report comprises an in-depth view of the progress of digital health, case studies, along with opinion from some key players in the industry.
Digital health empowers us with ways to improve outcomes and increase efficiency.
Part 2 of our report will look at how we can learn from failures in digital health, available [when available and how to access].
Our analysis regarding the evolution of what we believe is the development of the Healthcare Cloud. We discuss the siloed nature of HCIT in terms of legacy and cloud and discuss how we believe entities need to shift from point to platform solutions over time. We also lay out the fundamental underpinnings of what makes a compelling digital healthcare investment.
با گسترش فناوری اطلاعات و سرویس های مختلفی امروزه در زندگی انسان ها ارائه می شود حوزه سلامت و درمان هم بی بهره از این گسترش فناوری نبوده و در صورتی که سیاستمداران و برنامه ریزان کشور بتوانند از ظرفیت های ترکیب دانش پزشکی و فناوری اطلاعات بهره ببرند شاید با وجود افزایش جمعیت کهنسال و نیاز به رسیدگی های خاصی که در این قشر احساس می شود بتوان در کاهش هزینه های درمان گامی برداشت
Development Standards and Regulations for HealthTechElinext
Wearables, surgery robots, wellness platforms, and digital doctors. The new healthcare landscape is bright, full of novelties and breaking ideas. But before entering this market, you should learn the basic regulations and standards for HealthTech products. We gathered all the information for you in our new infographic.
How Healthcare is Adopting New Technologies? | 7 Best technology | CIO Women ...CIOWomenMagazine
The worldwide epidemic compelled the industry to adapt and innovate. It also described how healthcare is adopting new technologies in the following ten years.
The 10 Companies Booming in Healthcare Sectorinsightscare
Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”. This edition portrays the inspiring stories of the listed pre-eminent organizations that are shaping the future of healthcare through innovation and dedication.
Healthcare data and its impact upon the patient care decision process via accurate, real-time, reliable data from disparate sources is creating a digital health revolution. Data-driven healthcare is beginning to have a huge impact addressing the challenges of every provider, through efficient handling of huge volumes of patient care data.
Providers need to move towards real-time analytics that have become critical to demonstrate their quality of care, as reimbursement by government programs can be contingent upon how providers are measured in “Quality of Care”. For example, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, also called the Permanent Doc Fix, changes the way Medicare doctors are reimbursed with the implementation of a merit based incentive. The performance-based pressure is huge, which makes it imperative that every provider consider technology solutions. Read more at https://www.solix.com/solutions/data-driven-solutions/healthcare/
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...EY
Summary: This keynote address presented by Pamela Spence, EY Global Life Sciences Leader (pspence2@uk.ey.com) at MAPS 2018 – the annual meeting for Medical Affairs Professional Society – discusses our latest life sciences report and the industry demands for a customer-focused, data driven approach to health care. We describe the accelerating pace of change as technological advances and the escalating expectations of payers, physicians and patient consumers are combining to disrupt the life sciences business model. Data and algorithms that maximize health outcomes based on individual needs and preferences are becoming the ultimate health care consumable. To create value now and in a future that we call Life Sciences 4.0, life sciences companies must build – or participate in – interoperable information systems that collect, combine and share data. For more on our report, Progressions 2018 – Life Sciences 4.0, please go to www.ey.com/progressions
Unlocking Technology Opportunities in Value-Based Healthcare | Parimal Shah |...UCICove
About UCI Applied Innovation:
UCI Applied Innovation is a dynamic, innovative central platform for the UCI campus, entrepreneurs, inventors, the business community and investors to collaborate and move UCI research from lab to market.
About the Cove @ UCI:
To accelerate collaboration by better connecting innovation partners in Orange County, UCI Applied Innovation created the Cove, a physical, state-of-the-art hub for entrepreneurs to gather and navigate the resources available both on and off campus. The Cove is headquarters for UCI Applied Innovation, as well as houses several ecosystem partners including incubators, accelerators, angel investors, venture capitalists, mentors and legal experts.
Follow us on social media:
Facebook: @UCICove
Twitter: @UCICove
Instagram: @UCICove
LinkedIn: @UCIAppliedInnovation
For more information:
cove@uci.edu
http://innovation.uci.edu/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
2. TOPICS OF DISCUSSION
1
2
3
4
5
6
The Healthcare & Life Sciences Industry
2020
Analysis of attractiveness of each sub segments
The Post Covid-19 Disruption
Technologies & start-ups disrupting the status quo
Special focus on medical device industry: Global vs Indian
A concept note on syringe counterfeiting
3. Niche
Specialist
The New Healthcare Model
Important Players (*Proposed by KPMG)
Active
Portfolio
Companies
1. Healthcare’s reliance on digital
technology has risen. Healthcare 4.0:
Patient wearables, data analytics,
patient monitoring systems
2. Growth of quantum tech, AI in drug
development as well in the technology
which acts the medium of the
healthcare service
3. Covid-19 has increased the growth of
companies involved in support systems
eg IT, ITeS, Supply chain transformation
eg temperature controlled chains,
blockchain
4. Shift to outcome based care from value
based
Key Takeways
Virtual
Value chain
orchestrator
Challenges
Siloed data | Privacy of data | Cost
pressures & price ceilings by regulatory
bodies | Heterogeneous regulations|
Hyper competition in generics
Late stage
development
companies
Digital Tech/data
based company
Early stage
clinical discovery
4. KEY NUMBERS FROM PRIMARY
ANALYSIS
27 %
17.8
mn $
~ 2%
5.2
mn $
Biotech increase in total
funding over the last 5 years.
Maximum over other categories in
healthcare
Largest funding/deal:
Drug Discovery & drug
development 2nd fastest growing
segment and still has
Average Medical device funding
growth (*last 5 years). Remained
constant. Funding/deal has decreased.
Highest funding in Imaging, surgical &
therapeutic devices
Indias Medtech funding/deal (2020)
In india funding in line with global
average. Highest funding for AI
enabled healthcare services
Changes
observed?
1
2
3
4
• Biotech/Pharmac
eutics related
companies fastest
growing
• Patient
Monitoring
systems
generated more
funding than
expected, owning
to telehealth
demand
• Global Giants
Abbott, GE,
Phillips opened
incubation
programs leading
to medtech
funding
comparable to
global average
• Among
CBInsights top
150 startups
clinical
intelligence
biggest
technology while
healthcare
software &
services biggest
5. Virtual consultations by healthcare professionals will
become the mainstream care delivery model post-
pandemic. , 73% of the deals in 2020 globally have been
seed/angel or early-stage deals indicating that this
industry has a lot of opportunity for investors
Informatics and artificial intelligence (AI)
solutions addressing workflow automation and
operational analytics will witness 100% growth in
2020. eg. GE Healthcare‘s industry-first, FDA-
cleared Critical Care Suite AI tool. Teleradiology
& new patient delivery models for critical care to
drive growth
Rise of Covid-19 & Other Infectious Diseases:
Although diagnosis & treatment of lifestyle
diseases were the primary area of focus the 5bn
$ estimated infectious disease market became
the centre of attention. Walgreens & CVS trying
alternate models from traditional in-vitro testing
Segmentation of Market: The healthcare
industry includes various sub segments: The
major ones: pharma/life sciences, medical
devices, care delivery services,
insurance/payers. Across the service chain
segmented into Prevention, diagnosis,
treatment care
The rise of biotech: Both in terms of deal size
& funding. Med/biotech hits its highest
funding quarter since 20I8 Med/biotech
funding reached $6.2 billion in Q1 2020, the
highest quarter ever since Q3 2018
Funding Trends: 2020 fundings remained as
per the projected standards at 48 bn $
(including private equity deals). Growth driven
by the further rise of digital health companies
& biotech drug development.
The Healthcare Industry 2020: Key Insights
6. MAJOR DISRUPTOR:
TELEMEDICINE
The Covid disruption reduced funding of traditional healthcare services.
Need for faster care delivery models. Live monitoring, in home testing
were trends
81 bn $
21 %
Representatio
n in top 150
digital
startups list:
Estimated
Market
Potential
62 %
Teleconsultati
on &
Specialized
Tele Services
in India as a %
of total Tele-
heath Cos
A C C E L E R A T E D
D I G I T A L
P E N E T R A T I O N
L E S S W A I T I N G
T I M E , P R I M A R Y
H E A L T H C A R E
C O S T
D A T A
S E C U R I T Y |
R E G U L A T I O
N S
P E R C E P T I O N
A B O U T
Q U A L I T Y
I N F R A S T R U C T U R E
&
I N T E R O P E R A B I L I T Y
7. 1. Industry Average
Importance of Digital Tech
• AI, ML and Cloud
forming the backbone of
healthcare analytics
• Lifesciences 4.0 with a
patient centric
personalized medicine
• Based on number of deals
Data Management, wellness,
genomics top 3
• In medical device category:
max investment in
diagnostics
• Based on number of startups
since 2010 wellness,
genomics top category
• Microsoft ScaleUp & Microsoft
AI Factory: 35 investments
• Venture arm M12: Late stage
funder
• Top invested categories: Data
Management & Analytics and
Genomics companies
• Google Launchpad
Accelerator: 17 digital
health companies
• The top categories of
investment Genomics (18
deals), Clinical Research
(15), and Insurance &
Benefits (12)
• 31 investment in china & 18
in US
• 84 % investment + 16 %
from Accelerator program
• the two top investment
categories by deal volume
are Clinical Research and
Administrative Tools
WHERE DO BIG TECH GIANTS
INVEST?
Startups Invested in
8. Next-generation sequencing
(NGS):
3D-printing
Artificial intelligence (AI)
• Point-of-care (POC) diagnostics
Healthcare -
Life Sciences
Sector
Immunotherapy
Quantum Computing: From 15 years and costing $3
billion to 45 genomes/day at 1000$ for NGS.
2 lakh Amputations/year in US alone. 3d organs &
prosthetics can reduce cost from 50k $ to 100-500
$
Oncology is the biggest end use of all drug
development. Immunotherapy in the form of
Cart T tech, RNA therapy
Healthcare Companies using AI received higher
funding (1.8 mn $) vis a vis non adopters. Application
of AI for new drug development deals increased 5x in
last 5 years
Analysts expect the market for POC diagnostics will
total nearly $3 billion in 2021, up from $2.13 billion in
2015. Shift from FFS to Value Based Care to drive
growth
01
02
03
05
04
TOP TRENDS IDENTIFIED Technology Deep-Dive
9. Virtual reality (VR)
SML: Social Media
Listening
Convenient care
Telehealth
Healthcare -
Life Sciences
Sector
Biosensors and trackers
52 percent of consumers actively search online
for health. SML can access patient care data,
Quality of Life measure improvements in care.
CCS Insights expects 411 million wearable
devices to be sold in 2020.
77 percent of respondents of US Consumer
Survey 2018 choose retail clinics for their
convenience, 72 percent for speed of securing
an appointment, and 60 percent for after-hours
care
Even before Covid patent fillings among US
assisted care higher for Telehealth
equipments. Well being & care delivery apps
received highest funding 3.6 bn $ in 2019
06
07
08
10
09
TOP TRENDS IDENTIFIED Technology Deep-Dive
Research articles in Pubmed database have
increased over the last decade from 204 in 2004
to 720 in 2014 to 2567 in 2018 for VR. Proof of
concept: Facebook’s Oculus Rif
10. • US$2 billion deal to
acquire US home
dialysis equipment
maker NxStage
Medical Inc.
• 3,690 dialysis centers
making them a
global leader in both
manufacturing &
clinic operations.
• Focus on home
treatment Market
through the deal
• Partnered with
Fitbit & IBM
Watson
• To integrate
tracking for
patients living
with diabetes
• Augment data
for their
diabetes
management
app, Sugarwise
It is when incumbents perform
the NPD process by outsourcing
or patent sharing, acquisition of
a small niche player.
Advantages: Cost Effective,
Increases GTM time, benefit of
synergy
What is co-
invention?
• Strategic alliance
with IBM Watson
Health
• Focus on
population health
management and
value based
healthcare solutions
for hospitals
• To improve clinical
laboratory service
operations, and is
expected to benefit
more than
92 million patients
A look at corporate VC funding over the last
decade shows that it has been steady & constant.
Reason? Most incumbents invest in technologies
with long term benefits for more effective portfolio
optimization
Key Takeaway: Mapping key focus area of
investments by incumbents helped to shortlist
startups
THE TREND OF CO-
INVENTION
Fresenius Medical Siemens Medtronic
11. LIST OF SELECT STARTUPS
DISRUPTING THE STATUS QUO
Startups disrupting Labcorp’s traditional
health services model across the supply
chain
12. MEDICAL DEVICES: SNAPSHOT
Drug delivery and patient monitoring will personalize and
minimize invasiveness of drug delivery, through devices like
biostamps and smart inhalers. Novartis has partnered with
Qualcomm Life to develop an internet-connected inhaler
Assistive care and therapy services – like the biohybrid kidney –
will minimize the need for certain services (e.g. dialysis).
University of California have developed a first prototype of an
artificial implantable kidney the size of a coffee cup
Ingenious diagnosis and imaging will utilize DNA, nanobots and
Artificial Intelligence (AI) to speed up diagnosis, imaging
Innovative surgical interventions like autonomous surgical
robots and intelligent balloon catheters. Stryker launched FDA
approved robotic-arm assisted total knee arthroplasty
13. MEDICAL DEVICES: SNAPSHOT
care
23%
Diagnosis
19%
Prevention
8%
Treatment
50%
% breakup of stage of application
of Medical devices
care
Diagnosis
Prevention
Treatment
M A P P I N G S T A G E O F A P P L I C A T I O N O F S T A R T U P S I N V E S T E D B Y G E V E N T U R E , J & J
I N N O V A T I O N S H O W S M E D I C A L D E V I C E S F O R T R E A T M E N T A S P R I M A R Y A R E A O F
I N V E S T M E N T
N O N I M A G I N G D I A G N O S T I C S E A R N E D H I G H E R M A R G I N S T H E R E F O R E L E S S F O C U S O N
T H E M B Y I N C U M B E N T ’ S V C A R M S . R A D I O C A R D I O L O G Y , O N C O L O G Y M A I N A R E A O F
A P P L I C A T I O N
A L L I N C U M B E N T S I N V E S T I N A P R I M A R Y A R E A F O R S Y N E R G Y B E S I D E S M U L T I P L E
S E C O N D A R Y I N V E S T M E N T S . E G . J & J F O R I M A G I N G , A B B O T T : T D C A R D I O V A S C U L A R ,
B & D , M E D T R O N I C : T D , G E : R E S E A R C H E Q U I P M E N T S
Key Observations
Focus on patient centric modelling
KPI= Clinical + PROM (patient
related outcome measures)
India in growth phase while China
and USA in the saturation phase
Shift from Channel partner to a
solution provider
Top Indian Startups
• CBInsighst Top 150
• Ai enabled
• 16 mn $ funding, 6458
Crunchbase rank
14. SYRINGE
COUNTERFEITING
Pharma
Company
Initiatives
Brand
recognitio
n
Regulator
y Control
Consumer
Education
Tech
Based
Tracking
Retailer
Recognitio
n
How to
stop
counterfeiti
ng?
U S $ 1 6 3 B I L L I O N T O $ 2 1 7 B I L L I O N I N L O S T S A L E S | 1 0 % O F A L L M E D I C A L
P R O D U C T S C O U N T E R F E I T S | W H O E S T I M A T E S 5 0 % O N L I N E M E D I C A L
P R O D U C T S A S F A K E
B ) D E V I C E C O M P O N E N T S : C A R D I O V A S C U L A R
A N D O R T H O P E D I C P R O D U C T L I N E S
M A R K E T P O T E N T I A L : L O S S I N C O S T S 1 – 2 % O F R E V E N U E S & L O S S I N
R E V E N U E S I S 0 . 7 – 1 . 4 % O F R E V E N U E S . A V G T I M E T O R E U S E A F T E R
C O U N T E R F E I T R E P O R T I N G : 8 8 M O N T H S
T R A D I T I O N A L
C L A S S I F I C A T I O N O F A N T I -
C O U N T E R F E I T I N G T E C H
C O V E R T : 6 0 % O F
A L L
T E C H N O L O G I E S
Types Of
Counterfeit
products
A ) F I N I S H E D P R O D U C T S : B L O O D G L U C O S E
M O N I T O R I N G S Y S T E M S , S U R G I C A L S U T U R E S ,
C A T H E T E R S A N D H E A R T V A L V E S .
O V E R T : 1 0 %
F O R E N S I C
A N A L Y S I S : 3 0 %
15. NEW AGE TECHNOLOGIES
Nano-
Tech
Nano barcodes
Holography
Nanocompos
ite tags
Laser surface
authenticatio
n
Block-
chain
based
Supporting Tech
unique
cryptographic
identifiers
smart tags
IoT + Cloud
Quantum
Dots
Implant SER
technology
Encoding
Technology:
Quantum Codes
Master
batch
variety of polymers
polyamides
Acetal (POM)
PP, PE, PC
Challenges
Economic Barriers: Taggants costlier +
Cost to incorporate these packaging
techs range from 15-150 INR/tag
Technological challenge: Technology
to read these covert tech not accessible
SC TRANSFORMATIONS
Serialization L1 L2 L3 L4 L5
Device
Level
Packaging Site
Enterprise
Wide
Network
Serializatio
n + IoT +
Cloud
Benefits
16. Quantum Computing
• Cryptoseal: Funding $ 330 M, 6
Rounds, 13 investors
• Aquired by: Cloudfare
• Investors Y-Combinator
Product Technologies Supply Chain
transformations
PROOF OF CONCEPTS
Nano Tech Block chain
SMART SYRINGES
• Bit Encryption Assurance level 6+
• Deals with Merck, Pfizer worth 4bn $
• Imprinted on both glass & plastic
vials
• Patented Technology
Serialization
• L1-L5 Serialization end to
end
• Integrated with
appointment-booking
service DocSuggest + in-
home physician visits: Portea
Medical Group
• Packaged 300 mn codes
• Compliance with EU FMD,
DSCSA, DGFT, Saudi FDA and
Russia
Codes & Tag
generators
Crunch-
base Rank:
285241
Funding:
5.5 mn $
Familiar Handling | Tamper proof
| Retractable | Prefilled